|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
44,215,000 |
Market
Cap: |
4.18(M) |
Last
Volume: |
147 |
Avg
Vol: |
60,991 |
52
Week Range: |
$0.06 - $0.26 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Enzon Pharmaceuticals is engaged in existing licensing arrangements with other companies primarily related to sales of certain drug products that utilize Co.'s proprietary technology. Co. has a marketing agreement relating to the drug Vicineum.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
99,550 |
99,550 |
Total Buy Value |
$0 |
$0 |
$13,910 |
$13,910 |
Total People Bought |
0 |
0 |
1 |
1 |
Total Buy Transactions |
0 |
0 |
2 |
2 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2023-12-28 |
2023-09-26 |
2023-03-28 |
2022-03-28 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Read Randolph C |
Director |
|
2023-06-16 |
4 |
B |
$0.14 |
$11,922 |
D/D |
84,550 |
200,000 |
2.39 |
-26% |
|
Read Randolph C |
Director |
|
2023-06-14 |
4 |
B |
$0.13 |
$1,988 |
D/D |
15,000 |
115,450 |
2.31 |
2% |
|
Myrexis, Inc. |
10% Owner |
|
2021-08-13 |
4 |
S |
$0.39 |
$41,904 |
I/I |
(107,500) |
2,043,024 |
|
19% |
|
Read Randolph C |
Director |
|
2020-11-18 |
4 |
B |
$0.16 |
$7,875 |
D/D |
50,000 |
100,450 |
2.39 |
391% |
|
Read Randolph C |
Director |
|
2020-11-16 |
4 |
B |
$0.15 |
$7,623 |
D/D |
50,450 |
50,450 |
2.39 |
406% |
|
Bleznick Jordan |
Director |
|
2020-11-13 |
4 |
B |
$0.15 |
$15,380 |
D/D |
100,000 |
100,000 |
2.39 |
426% |
|
Icahn Carl C Et Al |
10% Owner |
|
2020-10-09 |
4 |
OE |
$0.00 |
$0 |
I/I |
39,277 |
39,277 |
|
- |
|
Icahn Carl C Et Al |
10% Owner |
|
2020-10-09 |
4 |
OE |
$0.00 |
$0 |
I/I |
29,457,750 |
36,056,636 |
|
- |
|
Pearce Michael Cooper |
See explanation of responses |
|
2020-08-05 |
4 |
B |
$0.20 |
$101,258 |
I/I |
506,292 |
2,100,524 |
0.01 |
21% |
|
Pearce Michael Cooper |
|
|
2020-08-03 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
9,518,748 |
|
46% |
|
Myrexis, Inc. |
See Footnote 1 |
|
2020-03-26 |
4/A |
B |
$0.14 |
$22,510 |
I/I |
160,785 |
633,264 |
0.01 |
- |
|
Xstelos Corp. |
10% Owner |
|
2020-03-26 |
4 |
B |
$0.14 |
$22,510 |
I/I |
160,785 |
633,264 |
1.5 |
21% |
|
Myrexis, Inc. |
See Footnote 1 |
|
2020-03-25 |
4/A |
B |
$0.14 |
$65,737 |
I/I |
469,551 |
472,479 |
0.01 |
- |
|
Xstelos Corp. |
10% Owner |
|
2020-03-25 |
4 |
B |
$0.14 |
$65,737 |
I/I |
469,551 |
472,479 |
1.5 |
23% |
|
Myrexis, Inc. |
See Footnote 1 |
|
2020-03-23 |
4/A |
B |
$0.14 |
$375 |
I/I |
2,678 |
2,928 |
0.01 |
- |
|
Xstelos Corp. |
10% Owner |
|
2020-03-23 |
4 |
B |
$0.14 |
$375 |
I/I |
2,678 |
2,928 |
1.42 |
29% |
|
Myrexis, Inc. |
|
|
2020-03-18 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
250 |
|
25% |
|
Myrexis, Inc. |
See Footnote 1 |
|
2020-03-13 |
4/A |
B |
$0.14 |
$2,661 |
I/I |
19,709 |
1,594,232 |
0.01 |
- |
|
Xstelos Corp. |
10% Owner |
|
2020-03-13 |
4 |
B |
$0.14 |
$2,661 |
I/I |
19,709 |
1,594,232 |
1.42 |
-5% |
|
Xstelos Corp. |
10% Owner |
|
2019-02-11 |
4 |
B |
$0.25 |
$3,750 |
I/I |
15,000 |
1,574,523 |
1.42 |
- |
|
Xstelos Corp. |
10% Owner |
|
2019-02-11 |
4 |
B |
$0.25 |
$9,000 |
D/D |
36,000 |
4,717,666 |
2.37 |
- |
|
Xstelos Corp. |
See Footnote 1 |
|
2019-01-07 |
4 |
B |
$0.26 |
$510 |
D/D |
2,000 |
4,681,666 |
2.37 |
- |
|
Xstelos Corp. |
See Footnote 1 |
|
2019-01-04 |
4 |
B |
$0.26 |
$638 |
D/D |
2,500 |
4,679,666 |
2.37 |
- |
|
Xstelos Corp. |
See Footnote 1 |
|
2019-01-03 |
4 |
B |
$0.26 |
$1,148 |
D/D |
4,500 |
4,677,166 |
2.37 |
- |
|
Xstelos Corp. |
See Footnote 1 |
|
2018-12-21 |
4 |
B |
$0.27 |
$84,100 |
I/I |
312,523 |
1,559,523 |
1.5 |
- |
|
72 Records found
|
|
Page 1 of 3 |
|
|